TRAF4 and colorectal carcinoma: Together, these results suggest that the TRAF4-p-CHK1 signaling plays a critical role in 5-Fu resistance and that a combination of 5-Fu with CHK1 inhibitors could be a promising strategy to overcome chemoresistance in CRC cells.